Pot sector falls into correction territory, but MedMen jumps after $682 million acquisition

  • 📰 MarketWatch
  • ⏱ Reading Time:
  • 1 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 4%
  • Publisher: 97%

United States News News

United States United States Latest News,United States United States Headlines

A key tracker of the marijuana industry has fallen into correction territory -- but there's still one pot stock that's a bright spot today.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 3. in US
 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

Igc

CRON up 8% and ACBFF up 5%. You ain’t smoking weed🌬😳

United States United States Latest News, United States United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Marijuana stocks to watch: MedMen turns a vision into reality with largest-ever U.S. pot mergerMedMen Enterprises co-founder Adam Bierman believes the company’s $682 million acquisition of PharmCann last week marks the culmination of the U.S. cannabis industry’s transformation from vision to reality. Ticker isn’t on robinhood?
Source: MarketWatch - 🏆 3. / 97 Read more »

High-end marijuana retailer MedMen just spent $682 million on the largest US cannabis acquisition in historyMedMen, one of the booming cannabis industry's most recognizable brands, acquired medical marijuana retailer PharmaCann in a $682 million stock transaction. It's the largest cannabis acquisition in the US to date. ShopMedMen Oh Hell Yea..... I own some stock LetsDoThis
Source: BusinessInsider - 🏆 729. / 51 Read more »

Marijuana stocks to watch: MedMen’s vision becomes reality with largest-ever U.S. pot mergerMedMen Enterprises co-founder Adam Bierman believes the company’s $682 million acquisition of PharmCann last week marks the culmination of the U.S. cannabis industry’s transformation from vision to reality.
Source: MarketWatch - 🏆 3. / 97 Read more »

'Retail is the place to be' in cannabis, says MedMen CEO after 'blockbuster' PharmaCann acquisitionJim Cramer sits down with MedMen co-founder and CEO Adam Bierman, whose cannabis retailer will absorb PharmaCann in the largest marijuana-related acquisition in U.S. history.
Source: CNBC - 🏆 12. / 72 Read more »

The CEO of the biggest cannabis company in the US reveals his strategy for defending against multi-billion private equity fundsBI PRIME: Hot off of a $682 million acquisition, Adam Bierman, the CEO of MedMen — now the biggest cannabis company in the US — opens up about who his biggest competition is and how he's defending against them.
Source: BusinessInsider - 🏆 729. / 51 Read more »

A competitor is emerging to challenge the marijuana retail chain dominating the industry, and it just closed a $640 million acquisitionBI PRIME: iAnthus, a multistate cannabis dispensary operator, acquired Toronto-based MPX Bioceutical in a $640 million all-stock transaction. The deal comes on the heels of rival MedMen's $682 million acquisition of PharmaCann. BIPrime Are they considering a 'joint' venture?
Source: BusinessInsider - 🏆 729. / 51 Read more »

Cannabis industry shops for a suit and tieMoney is pouring into weed as valuations rise and legal barriers fall – nudged further by recent U.S. election results. Companies like Canopy, Aurora and MedMen are starting to take on a veneer of acceptability. That doesn’t make them good investments, but it’s progress.
Source: Breakingviews - 🏆 470. / 51 Read more »

High-end marijuana retailer MedMen just spent $682 million on the largest US cannabis acquisition in historyMedMen, one of the booming cannabis industry's most recognizable brands, acquired medical marijuana retailer PharmaCann in a $682 million stock transaction. It's the largest cannabis acquisition in the US to date. ShopMedMen Oh Hell Yea..... I own some stock LetsDoThis
Source: BusinessInsider - 🏆 729. / 51 Read more »